Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation.
about
Monoclonal antibody therapy and renal transplantation: focus on adverse effectsAtypical hemolytic uremic syndrome: from diagnosis to treatmentAtypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literatureAn international consensus approach to the management of atypical hemolytic uremic syndrome in children.Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence.Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.Post-bone marrow transplant thrombotic microangiopathy.Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.Anti-complement-factor H-associated glomerulopathies.De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.Complement involvement in kidney diseases: From physiopathology to therapeutical targetingComplement related kidney diseases: Recurrence after transplantation.Primary disease recurrence—effects on paediatric renal transplantation outcomes.Targeting the complement cascade: novel treatments coming down the pike.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies.Kidney Diseases Associated With Alternative Complement Pathway Dysregulation and Potential Treatment Options.Precision Transplant Medicine: Biomarkers to the Rescue.Belgian consensus statement on the diagnosis and management of patients with atypical hemolytic uremic syndrome.Thrombotic Microangiopathy and the Kidney.Pediatric combined liver-kidney transplantation: a single-center experience of 18 cases.De Novo Atypical Haemolytic Uremic Syndrome after Kidney Transplantation.Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in and recurrent diseasesThrombotic microangiopathy after renal transplantation: Current insights in and recurrent disease
P2860
Q26826880-0DC6BFE4-0BFB-480C-BB84-179E055CC877Q27023137-8D11FD55-CCD6-4756-827C-6C55F737B4F9Q33419812-94F4E972-7348-4937-9FED-E501EB04DBF5Q33421861-D839AD19-D809-4D82-A9C7-DC6656DDC1C2Q33423305-2D20229A-8A18-42B1-9408-F5AA05A7F3DCQ33424946-703F64D4-5633-49D0-BD58-532F5D13AE65Q33430697-25C20B41-4A6E-4167-97B5-617F50447AD2Q33430817-5A035B1B-0DB3-486C-B9B1-129749C28E97Q33434103-9ED4BFA8-F45F-4026-934B-044D33AFFEEFQ33439133-B7DB3A2E-C2E3-4684-B2A9-4A79F3DF7560Q33783126-61E32AC1-2721-46A7-9322-1B73F1E24985Q35567841-CF797D11-ABDB-4AC0-9F48-ED3A0F2238A9Q37522557-011293F4-B2EB-47D5-AC14-CD0E9BDBDF92Q38445275-42D76FC3-22F9-48EE-880E-BF729347DCF5Q38850489-1F89A77B-F064-404F-8FA6-A5182CBC03F5Q42086661-4676AC3E-85C5-4332-8D75-91A75275E05FQ47096270-211C0B6A-9FD5-466C-A166-2F2EFAB8782AQ47327197-864C6A27-9611-44BB-B2D6-5D0D3BA2D918Q47656083-4847968B-A794-4072-9EEB-D5AA66BCF4CAQ48146844-977539F1-D40D-4EF0-BA25-0EED612C0A51Q50085453-AA8FA972-B137-4CA0-BB5D-B351A65EFBEFQ53127026-72758669-9A51-4CE8-A1AE-B790F93E457BQ55128066-0BCA3B84-71B6-4C99-87F5-347E0BA4676EQ58120548-13D006CB-6710-4757-A06C-405DA045809DQ58754943-7BAA1A02-7D2A-419D-9C25-C7CD87E48CF0
P2860
Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeted strategies in the pre ...... after kidney transplantation.
@ast
Targeted strategies in the pre ...... after kidney transplantation.
@en
type
label
Targeted strategies in the pre ...... after kidney transplantation.
@ast
Targeted strategies in the pre ...... after kidney transplantation.
@en
prefLabel
Targeted strategies in the pre ...... after kidney transplantation.
@ast
Targeted strategies in the pre ...... after kidney transplantation.
@en
P2093
P1476
Targeted strategies in the pre ...... e after kidney transplantation
@en
P2093
Chantal Loirat
Christophe Legendre
Heather Morris
Véronique Frémeaux-Bacchi
P304
P356
10.1016/J.TRRE.2013.07.003
P577
2013-08-12T00:00:00Z